Literature DB >> 24686393

microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.

Stefan Deneberg1, Meena Kanduri2, Dina Ali1, Sofia Bengtzen1, Mohsen Karimi1, Ying Qu1, Eva Kimby1, Larry Mansouri3, Richard Rosenquist3, Andreas Lennartsson4, Sören Lehmann1.   

Abstract

A commonly deleted region in chronic lymphocytic leukemia (CLL) is the 11q22-23 region, which encompasses the ATM gene. Evidence suggests that tumor suppressor genes other than ATM are likely to be involved in CLL with del(11q). A microRNA (miR) cluster including the miR-34b and miR-34c genes is located, among other genes, within the commonly deleted region (CDR) at 11q. Interestingly, these miRs are part of the TP53 network and have been shown to be epigenetically regulated. In this study, we investigated the expression and methylation status of these miRs in a well-characterized cohort of CLL, including cases with/without 11q-deletion. We show that the miR-34b/c promoter was aberrantly hypermethylated in a large proportion of CLL cases (48%, 25/52 cases). miR-34b/c expression correlated inversely to DNA methylation (P = 0.003), and presence of high H3K37me3 further suppressed expression regardless of methylation status. Furthermore, increased miR-34b/c methylation inversely correlated with the presence of 11q-deletion, indicating that methylation and del(11q) independently silence these miRs. Finally, 5-azacytidine and trichostatin A exposure synergistically increased the expression of miR-34b/c in CLL cells, and transfection of miR-34b or miR-34c into HG3 CLL cells significantly increased apoptosis. Altogether, our novel data suggest that miR-34b/c is a candidate tumor suppressor that is epigenetically silenced in CLL.

Entities:  

Keywords:  DNA methylation; chronic lymphatic leukemia; epigenetics; micro-RNA

Mesh:

Substances:

Year:  2014        PMID: 24686393      PMCID: PMC4053441          DOI: 10.4161/epi.28603

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  34 in total

1.  Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation.

Authors:  Qihuang Jin; Li-Rong Yu; Lifeng Wang; Zhijing Zhang; Lawryn H Kasper; Ji-Eun Lee; Chaochen Wang; Paul K Brindle; Sharon Y R Dent; Kai Ge
Journal:  EMBO J       Date:  2010-12-03       Impact factor: 11.598

2.  Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia.

Authors:  L Mansouri; L-A Sutton; V Ljungström; E F Sörqvist; R Gunnarsson; K E Smedby; G Juliusson; K Stamatopoulos; M Nilsson; R Rosenquist
Journal:  Leukemia       Date:  2013-10-31       Impact factor: 11.528

3.  Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.

Authors:  R Gunnarsson; A Isaksson; M Mansouri; H Göransson; M Jansson; N Cahill; M Rasmussen; J Staaf; J Lundin; S Norin; A M Buhl; K E Smedby; H Hjalgrim; K Karlsson; J Jurlander; G Juliusson; R Rosenquist
Journal:  Leukemia       Date:  2009-09-10       Impact factor: 11.528

Review 4.  Importance of genetics in chronic lymphocytic leukemia.

Authors:  Thorsten Zenz; Daniel Mertens; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Blood Rev       Date:  2011-03-23       Impact factor: 8.250

5.  Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.

Authors:  Norimitsu Tanaka; Shinichi Toyooka; Junichi Soh; Takafumi Kubo; Hiromasa Yamamoto; Yuho Maki; Takayuki Muraoka; Kazuhiko Shien; Masashi Furukawa; Tsuyoshi Ueno; Hiroaki Asano; Kazunori Tsukuda; Keisuke Aoe; Shinichiro Miyoshi
Journal:  Lung Cancer       Date:  2011-11-01       Impact factor: 5.705

6.  Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.

Authors:  Torsten Haferlach; Alexander Kohlmann; Lothar Wieczorek; Giuseppe Basso; Geertruy Te Kronnie; Marie-Christine Béné; John De Vos; Jesus M Hernández; Wolf-Karsten Hofmann; Ken I Mills; Amanda Gilkes; Sabina Chiaretti; Sheila A Shurtleff; Thomas J Kipps; Laura Z Rassenti; Allen E Yeoh; Peter R Papenhausen; Wei-Min Liu; P Mickey Williams; Robin Foà
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

7.  Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.

Authors:  Meena Kanduri; Millaray Marincevic; Anna M Halldórsdóttir; Larry Mansouri; Katarina Junevik; Stavroula Ntoufa; Hanna Göransson Kultima; Anders Isaksson; Gunnar Juliusson; Per-Ola Andersson; Hans Ehrencrona; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Epigenetics       Date:  2012-11-15       Impact factor: 4.528

8.  miR-34a as part of the resistance network in chronic lymphocytic leukemia.

Authors:  Thorsten Zenz; Julia Mohr; Eric Eldering; Arnon P Kater; Andreas Bühler; Dirk Kienle; Dirk Winkler; Jan Dürig; Marinus H J van Oers; Daniel Mertens; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

9.  The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.

Authors:  Takayuki Muraoka; Junichi Soh; Shinichi Toyooka; Keisuke Aoe; Nobukazu Fujimoto; Shinsuke Hashida; Yuho Maki; Norimitsu Tanaka; Kazuhiko Shien; Masashi Furukawa; Hiromasa Yamamoto; Hiroaki Asano; Kazunori Tsukuda; Takumi Kishimoto; Takemi Otsuki; Shinichiro Miyoshi
Journal:  Lung Cancer       Date:  2013-10-10       Impact factor: 5.705

10.  miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer.

Authors:  Lukas Vrba; José L Muñoz-Rodríguez; Martha R Stampfer; Bernard W Futscher
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more
  14 in total

1.  Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b/c in Neuronal Cells.

Authors:  Claudia Consales; Claudia Cirotti; Giuseppe Filomeni; Martina Panatta; Alessio Butera; Caterina Merla; Vanni Lopresto; Rosanna Pinto; Carmela Marino; Barbara Benassi
Journal:  Mol Neurobiol       Date:  2017-10-16       Impact factor: 5.590

2.  Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry.

Authors:  Xiaobin Cui; Xi Chen; Weiwei Wang; Aimin Chang; Lan Yang; Chunxia Liu; Hao Peng; Yutao Wei; Weihua Liang; Shugang Li; Ning Wang; Wei Liu; Jianming Hu; Wenjie Zhang; Lidong Wang; Yunzhao Chen; Feng Li
Journal:  Epigenetics       Date:  2017-07-13       Impact factor: 4.528

3.  Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.

Authors:  Linlin Shao; Zheng Chen; Wael El-Rifai; Dunfa Peng; Mohammed Soutto; Shoumin Zhu; Andreia Bates; Shutian Zhang
Journal:  Mol Cancer Res       Date:  2018-02-16       Impact factor: 5.852

Review 4.  MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?

Authors:  Katrien Van Roosbroeck; George A Calin
Journal:  Semin Oncol       Date:  2016-02-08       Impact factor: 4.929

5.  Novel mechanisms of regulation of miRNAs in CLL.

Authors:  Veronica Balatti; Mario Acunzo; Yuri Pekarky; Carlo M Croce
Journal:  Trends Cancer       Date:  2016-03

6.  ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer.

Authors:  Takuya Hasegawa; Ryohei Adachi; Hitoshi Iwakata; Takayoshi Takeno; Koji Sato; Toshiyuki Sakamaki
Journal:  FEBS Open Bio       Date:  2017-07-06       Impact factor: 2.693

Review 7.  Regulatory mechanisms of microRNA expression.

Authors:  Lyudmila F Gulyaeva; Nicolay E Kushlinskiy
Journal:  J Transl Med       Date:  2016-05-20       Impact factor: 5.531

8.  MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.

Authors:  Lufang Zhang; Lushan Wang; Dong Dong; Zhiyong Wang; Wei Ji; Man Yu; Fei Zhang; Ruifang Niu; Yunli Zhou
Journal:  Cell Prolif       Date:  2018-10-17       Impact factor: 6.831

Review 9.  Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets.

Authors:  Giacomo Andreani; Giovanna Carrà; Marcello Francesco Lingua; Beatrice Maffeo; Mara Brancaccio; Riccardo Taulli; Alessandro Morotti
Journal:  Cancers (Basel)       Date:  2020-03-09       Impact factor: 6.639

10.  Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.

Authors:  Justyna A Wierzbinska; Reka Toth; Naveed Ishaque; Karsten Rippe; Jan-Philipp Mallm; Lara C Klett; Daniel Mertens; Thorsten Zenz; Thomas Hielscher; Marc Seifert; Ralf Küppers; Yassen Assenov; Pavlo Lutsik; Stephan Stilgenbauer; Philipp M Roessner; Martina Seiffert; John Byrd; Christopher C Oakes; Christoph Plass; Daniel B Lipka
Journal:  Genome Med       Date:  2020-03-18       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.